Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for CRE and VRE Colonization
NCT03479710Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Feb 2018
- Primary completion
- Jul 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Enterobacteriaceae colonization, Enterococcus colonization, sponsored by The Chinese University of Hong Kong. Started Feb 2018; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Enterobacteriaceae colonizationEnterococcus colonization
Beyond the preview
Go deeper on NCT03479710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03479710.